Investors encouraged to join DexCom class action lawsuit. Allegations include unapproved design changes to G6/G7 glucose monitors, FDA warning, and health risks. Deadline Dec 26, 2025.

Dexcom’s G6 (left) and G7 (right) side-by-side. [Image from Dexcom] A Dexcom (NSDQ:DXCM) communication on its website states that it will soon cease manufacturing for its G6 continuous glucose monitor ...

Thank you for taking the first step to join the Yale SOM community. Our aim is to make the application process as straightforward as possible. Please review the information provided below, including ...

The Insulet Omnipod 5 pump and Dexcom G7 15 Day CGM. [Images courtesy of the companies] Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom ...